Dr. Hugh Davies March 27, OEH Seminar

Abstract: The number of people receiving antineoplastic drug treatment for cancer is increasing as the population ages and more people are diagnosed with cancer. While these drugs are powerful tools in the fight against cancer exposure to these drugs can also cause genetic damage miscarriages and cancer in otherwise healthy people. Despite the dissemination of safe handling practices, healthcare workers and others such as veterinarians continue to be exposed through surface contamination. Guidelines such as USP Chapter 800 call for routine workplace surveillance but do not provide detailed guidance on how this should be done or how to interpret surface wipe samples. The SURveillance For AntiCancer drugs Exposure Study (SurFACES) sampled up to 20 different surfaces monthly at nine facilities in the US and Canada for one year, and obtained 2000 samples, each tested for 11 antineoplastic drugs. In this presentation we will characterize exposures found at the sites, discuss spatial and temporal patterns and determinants of exposures, and discuss how the findings can be used to provide improved AD surveillance guidance to practitioners.

Presented by: Dr. Hugh Davies

Weblink: https://www.spph.ubc.ca/oeh-seminars/